DCAF1 inhibits the NF-κB pathway by targeting p65

Immunol Lett. 2022 Sep:249:33-42. doi: 10.1016/j.imlet.2022.08.005. Epub 2022 Aug 31.

Abstract

DCAF1 is considered to be a general substrate-recognizing subunit of E3 ligases, it has been implicated to be directly involved in different cellular processes. DCAF1 is also defined as a constitutive binding partner of viral protein R (Vpr) of the human immunodeficiency virus type 1 (HIV-1) and is essential for functions of Vpr. Here, we revealed that activation of NF-κB by virion-associated Vpr proteins highly depends on DCAF1, and that exogenous DCAF1 is capable of restraining NF-κB induction by external stimuli. Depletion of DCAF1 augments NF-κB activation. DCAF1 significantly inhibits the nuclear transportation of p65 through interactions with p65, after activation of the NF-κB pathway. Moreover, two main motifs of DCAF1 are identified to promote its inhibitory effects on the NF-κB pathway. Taken together, we propose a new role of DCAF1 in regulating cellular immune responses, beyond the function as a general adaptor for other cytokines or viral proteins.

Keywords: DCAF1; NF-κB; Nuclear transport; interaction; p65.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Carrier Proteins
  • Cytokines / metabolism
  • HIV-1* / physiology
  • Humans
  • NF-kappa B / metabolism
  • Ubiquitin-Protein Ligases / metabolism
  • vpr Gene Products, Human Immunodeficiency Virus* / metabolism

Substances

  • Carrier Proteins
  • Cytokines
  • NF-kappa B
  • vpr Gene Products, Human Immunodeficiency Virus
  • Ubiquitin-Protein Ligases